ChemicalBook > Product Catalog > Analytical Chemistry > Standard > Pharmaceutical Impurity Reference Standards > Tofacitinib Impurity 45
Tofacitinib Impurity 45
Tofacitinib Impurity 45 Basic information
- Product Name:
- Tofacitinib Impurity 45
- Synonyms:
-
- Tofacitinib Impurity 45
- CP-690550 N-Hydroxyl
- (3R,4R)-3-[(7-Hydroxy-7H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-1-piperidinepropanenitrile
- 1-Piperidinepropanenitrile, 3-[(7-hydroxy-7H-pyrrolo[2,3-d]pyrimidin-4-yl)methylamino]-4-methyl-β-oxo-, (3R,4R)-
- Tofacitinib Impurity 172
- CAS:
- 2407039-29-4
- MF:
- C16H20N6O2
- MW:
- 328.38
- Mol File:
- 2407039-29-4.mol
More
Less
Tofacitinib Impurity 45 Chemical Properties
- Melting point:
- >144°C (dec.)
- Boiling point:
- 625.5±65.0 °C(Predicted)
- Density
- 1.39±0.1 g/cm3(Predicted)
- storage temp.
- -20°C Freezer, Under inert atmosphere
- solubility
- DMSO (Slightly), Methanol (Slightly, Sonicated)
- form
- Solid
- pka
- 6.04±0.60(Predicted)
- color
- Light Brown to Brown
More
Less
Tofacitinib Impurity 45Supplier
ChemStrong Scientific Co.,Ltd
- Tel
- 0755-0755-66853366 13670046396
- sales@chem-strong.com
Hubei Yangxin Medical Technology Co., Ltd.
- Tel
- 15374522761
- 3003392093@qq.com
ANHUI WITOP BIOTECH CO., LTD
- Tel
- +8615255079626
- eric@witopchemical.com
Standardpharm Co. Ltd.
- Tel
- 86-714-3992388
- overseasales1@yongstandards.com
Tianjin shijia biomedical technology co., LTD
- Tel
- 15022261580
- tjshj1212@163.com
More
Less
Tofacitinib Impurity 45(2407039-29-4)Related Product Information
- (3R,4R)-N,1,4-trimethyl-N-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}piperidin-3-amine
- N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
- Tofacitinib Impurity
- Tofacitinib Impurity 36
- 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine
- 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]-
- 1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)-
- 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide
- 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile
- N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine
- Tofacitinib Impurity
- butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate
- 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI)
- N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide
- (3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine
- 1-BENZYL-N,4-DIMETHYLPIPERIDIN-3-AMINE DIHYDROCHLORIDE
- Tofacitinib Related Compound
- Tofacitinib Impurity 2